Αποτελέσματα Αναζήτησης
3 Νοε 2024 · Table 1 Patient characteristics for all advanced non-small cell lung cancer patients treated with 1 L pembrolizumab mono- or combination therapy in Norway (real-world) or clinical trials (Keynote ...
NCI supports clinical trials studying new and more effective ways to detect and treat cancer. Find clinical trials for non-small cell lung cancer.
4 Μαρ 2024 · Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
26 Σεπ 2024 · Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of NSCLC has improved...
6 Αυγ 2024 · Targeted therapies and immunotherapies have radically improved treatment for advanced non-small-cell lung cancer (NSCLC). Tyrosine kinase inhibitors targeting oncogenic driver mutations continue to evolve over multiple generations to enhance effectiveness and tackle drug resistance.
In this Special Issue, entitled “Treatments for Non-Small Cell Lung Cancer: The Multiple Options for Precision Medicine”, our goal is to provide an overview of advances in lung cancer management at different disease stages. While the number of actionable molecular alterations is growing, current guidelines recommend comprehensive genotyping ...
Non-small cell lung cancer is a type of cancer that forms in the tissues of the lung. There are several types of non-small cell lung cancer. Smoking is the major risk factor for non-small cell lung cancer. Signs and symptoms of non-small cell lung cancer include coughing and shortness of breath.
